Twitter | Search | |
UCLA Fights Cancer
UCLA Jonsson Comprehensive Cancer Center - The end of cancer begins with research.
1,165
Tweets
134
Following
8,146
Followers
Tweets
UCLA Fights Cancer Jun 22
This type of "living drug" is a way to harness the immune system to seek and destroy cancers using your own living cells. UCLA is one of few centers in U.S. to offer FDA-approved treatment outside clinical trials for patients like Josh.
Reply Retweet Like
UCLA Fights Cancer retweeted
UCLA Health News Jun 21
Dr. John Timmerman harnesses CAR T therapy to cure patient’s lymphoma
Reply Retweet Like
UCLA Fights Cancer Jun 21
Did you know grilling meats can increase the risk of cancer? Dr. Catherine Carpenter shares a few simple changes with that can help lower that risk.
Reply Retweet Like
UCLA Fights Cancer retweeted
OncLive.com Jun 20
Dr. Finn of Discusses the Pooled Analysis of REACH and REACH-2 in HCC
Reply Retweet Like
UCLA Fights Cancer retweeted
UCLA Health Jun 19
Thank U for tuning in to today's ! Learn more about eye cancer and the latest treatments with Dr. Tara McCannel ➨ .
Reply Retweet Like
UCLA Fights Cancer retweeted
DGSOM at UCLA Jun 15
David Sabatini of and is the 2018 Switzer Prize recipient. Sabatini’s pioneering discoveries of mechanisms that regulate cell growth are propelling into potential treatments for cancer and other diseases.
Reply Retweet Like
UCLA Fights Cancer retweeted
HemOnc Today Jun 16
plus improves PFS for advanced according to data presented at by Dr. Slamon of
Reply Retweet Like
UCLA Fights Cancer retweeted
Cancer Research Institute Jun 16
Checkpoint help our T cells eliminate tumor cells, but these CRI-funded researchers discovered how some tumors learn to evade T cells. Now, scientists are developing strategies to overcome resistance.
Reply Retweet Like
UCLA Fights Cancer retweeted
Parker Institute Jun 15
We at because we believe in the power of our immune systems to white-out cancer! Check out our growing team of at PICI!
Reply Retweet Like
UCLA Fights Cancer retweeted
OncLive SOSS Jun 14
What percentage of patients receive mastectomy versus lumpectomy? Maggie DiNome, MD, of tells us
Reply Retweet Like
UCLA Fights Cancer retweeted
Cancer Research Institute Jun 15
We are fearless in the face of . today to stand with science and cancer research.
Reply Retweet Like
UCLA Fights Cancer retweeted
UCLA Health Jun 14
The biggest modifiable risk factor that has been linked to cancer is , but the cause is not entirely understood
Reply Retweet Like
UCLA Fights Cancer retweeted
Dr. Deanna Attai Jun 14
review article - breast cancer in men via
Reply Retweet Like
UCLA Fights Cancer retweeted
UCLA Broad Stem Cell Jun 13
“A key feature of the nanospears is that we can guide them individually or in groups, like remote-controlled drones using a handheld or rotating magnet.” via
Reply Retweet Like
UCLA Fights Cancer Jun 13
Checkpoint blockade therapy is changing the face of cancer treatment – but not every patient responds to and there is an urgent need to identify ways to improve its efficacy. Here’s how JCCC researchers are working to fix this problem.
Reply Retweet Like
UCLA Fights Cancer Jun 12
How UCLA's Dr. Fuyuhiko Tamanoi and his team created an "Egg Tumor Model" to analyze cancer.
Reply Retweet Like
UCLA Fights Cancer retweeted
DGSOM at UCLA Jun 12
Dean Kelsey Martin applauds the National Academies of Sciences for taking on the important topic of sexual harassment in academia. Transformative change is clearly needed. is committed to a workplace free from all forms of harassment.
Reply Retweet Like
UCLA Fights Cancer Jun 11
These are the scientists who work tirelessly to find better treatments for people with cancer. This group of researchers from , & have already made a huge impact in the lives of so many, but it’s just the beginning.
Reply Retweet Like
UCLA Fights Cancer retweeted
Parker Institute Jun 11
PICI researchers find new mutations linked to colorectal and resistance
Reply Retweet Like
UCLA Fights Cancer retweeted
UCLA Health News Jun 4
This ability of cancer to change its genes — immunoediting — had never been described in colon cancer before. The new understanding could help researchers develop new immunotherapies that target those genetic changes.
Reply Retweet Like